Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

LANVIS 40 MG COMPRIMIDOS - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/LANVIS 40 MG COMPRIMIDOS

Approved

STANDARD

LANVIS 40 MG COMPRIMIDOS

Aspen Pharma Trading Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Mar 10, 2021
Approval ID: e8b579bd57679ec8
Company: Aspen Pharma Trading Limited
Type: Standard

Approval Details

Approval Id: e8b579bd57679ec8
Drug Cima Aemps Name: LANVIS 40 MG COMPRIMIDOS
Register Number: 84019
Holder Company Name: Aspen Pharma Trading Limited
Marketing Company Name: Aspen Pharmacare Espana S.L.
Holder Company Detail Path: /organization/aspen-pharma-trading-limited
Authorization Date: 2021-03-10
Dosage Form: COMPRIMIDO
Dose: 40 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Aspen Pharma Trading Limited
Company Detail Path: /organization/aspen-pharma-trading-limited

Company Information

Pharmaceutical Company Name: ASPEN PHARMA TRADING LIMITED
Country Name: Ireland
City Name: saggart,country_ie
Address: 3016 Lake Drive

Active Ingredients

TIOGUANINA

40 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Mar 10, 2021

Approval ID

e8b579bd57679ec8

Type

Standard

Back to CIMA-AEMPS Approvals